Oncogenic Ras and transforming growth factor-β synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition

Molecular Cancer Research

Volumn 6, Issue 7, 2008, Pages 1124-1136

  Kanies, Cindy L ^a   Smith, J Joshua ^a,b   Kis, Christian ^b   Schmidt, Carl ^b   Levy, Shawn ^b   Khabar, Khalid S A ^d   Morrow, Jason ^a,c   Deane, Natasha ^b,c   Dixon, Dan A ^e   Beauchamp, R Daniel ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; MESSENGER RNA; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; PROTEIN P21; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL TRANSFORMATION; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MESENCHYME CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA STABILITY; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; DISEASE COURSE; DNA MICROARRAY; EPITHELIUM; GENE EXPRESSION PROFILING; GENETICS; MESODERM; METABOLISM; MOUSE; PATHOLOGY; PROTEIN BINDING; REGULATORY RNA SEQUENCE; REPRODUCIBILITY;

RATTUS; RODENTIA;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DISEASE PROGRESSION; EPITHELIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MESODERM; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEIN P21(RAS); PROTEIN BINDING; RATS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; REPRODUCIBILITY OF RESULTS; RNA STABILITY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 51649116097     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-2095     Document Type: Article

References (57)

1. Bos J, Fearon E, Hamilton S, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-7.
2. Lee S, Lee J, Soung Y, et al. Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase. APMIS 2004;112:233-8.
3. Kurokowa M, Lynch K, Podolsky D. Effects of growth factors on an intestinal epithelial cell line: transforming growth factor B inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun 1987;142:775-82.
4. Filmus J, Zhao J, Buick R. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor B-1 (TGF-β1) and alters the number and type of TGF-β1 receptors in rat intestinal epithelial cell clones. Oncogene 1992;7:521-6.
5. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
6. Derynck R, Goeddel D, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-12.
7. Robson H, Anderson E, James R, Schofield P. Transforming growth factor β1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 1996;74:753-8.
8. Friedman E, Gold L, Klimstra D, Zeng Z, Winawer S, Cohen A. High levels of transforming growth factor β1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 1995;4:549-54.
9. Cui W, Fowlis D, Bryson S, et al. TGFB1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-42.
10. Saha D, Datta P, Beauchamp R. Oncogenic ras represses transforming growth factor-B/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem 2001;276:29531-7.
11. Fujimoto K, Sheng H, Shao J, Beauchamp R. Transforming growth factor-β1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells. Exp Cell Res 2001;266:239-49.
12. Game S, Huelsen A, Patel V, et al. Progressive abrogation of TGF-β1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Int J Cancer 1992;52:461-70.
13. Kretzschmar M, Doody J, Timokhina I, Massagué J. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev 1999;13:804-16.
14. Oft M, Heider K, Beug H. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998;8:1243-52.
15. Santibáñez J, Iglesias M, Frontelo P, Martínez J, Quintanilla M. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-β(1) in transformed keratinocytes. Biochem Biophys Res Commun 2000;273:521-7.
16. Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res 2003;63:7760-8.
17. Kim E, Kim M, Moon A. Transforming growth factor (TGF)-β in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 2005;29:84-91.
18. Xie L, Law B, Chytil A, Brown K, Aakre M, Moses H. Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 2004;6:603-10.
19. Roman C, Morrow J, Whitehead R, Beauchamp R. Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-β(1) in immortalized mouse colonocytes expressing oncogenic Ras. J Gastrointest Surg 2002;6:304-9.
20. Sheng H, Shao J, Dixon D, et al. Transforming growth factor-β1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 2000;275:6628-35.
21. Dixon D, Tolley N, King P, et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 2001;108:1657-65.
22. Fujimoto K, Hosotani R, Wada M, et al. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer 1998;34:1439-47.
23. Wong M, Cheung N, Yuen S, Leung S, Chung L. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression. Int J Cancer 1999;81:845-50.
24. Takahashi Y, Kitadai Y, Bucana C, Cleary K, Ellis L. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
25. Konno H, Tanaka T, Baba M, et al. Quantitative analysis of vascular endothelial growth factor in colon cancer. Clinical and experimental. Eur Surg Res 1998;30:273-8.
26. Masunaga R, Kohno H, Dhar D, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 2000;6:4064-8.
27. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois R. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
28. Abdelrahim M, Safe S. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol 2005;68:317-29.
29. Kim S, Seo J, Lee Y, et al. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells. Oncology 2005;68:204-11.
30. Nishikawa M, Stapleton P, Freeman T, Gaughan J, Matsuda T, Daly J. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. J Am Coll Surg 2004;199:428-35.
31. Levy A, Levy N, Wegner S, Goldberg M. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333-40.
32. Shima D, Deutsch U, D'Amore P. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203-8.
33. Claffey K, Shih S, Mullen A, et al. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 1998;9:469-81.
34. Levy N, Chung S, Furneaux H, Levy A. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 1998;273:6417-23.
35. Bakheet T, Williams B, Khabar K. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 2006;34:D111-4.
36. Ross H, Sato N, Ueyama Y, Koeffler H. Cytokine messenger RNA stability is enhanced in tumor cells. Blood 1991;77:1787-95.
37. Lee C, Bradley G, Ling V. Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo. J Cell Physiol 1998;177:1-12.
38. Halees AS, El-Badrawi R, Khabar KS. ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res 2008;36:D137-40.
39. Hollams EM, Giles KM, Thomson AM, Leedman PJ. mRNA stability and the control of gene expression: implications for human disease. Neurochem Res 2002;27:957-80.
40. Denkert C, Weichert W, Pest S, et al. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 2004;64:189-95.
41. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A 1986;83:1670-4.
42. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67.
43. Audic Y, Hartley R. Post-transcriptional regulation in cancer. Biol Cell 2004;96:479-98.
44. Bevilacqua A, Ceriani M, Capaccioli S, Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 2003;195:356-72.
45. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 2003;11:113-26.
46. Fan X, Steitz J. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 1998;17:3448-60.
47. Erkinheimo T, Lassus H, Sivula A, et al. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 2003;63:7591-4.
48. Heinonen M, Bono P, Narko K, et al. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 2005;65:2157-61.
49. D'Abaco G, Whitehead R, Burgess A. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol Cell Biol 1996;16:884-91.
50. Irizarry R, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
51. Storey J, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-5.
52. Schefe J, Lehmann K, Buschmann I, Unger T, Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med 2006;84:901-10.
53. Rubie C, Kempf K, Hans J, et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005;19:101-9.
54. DuBois R, Awad J, Morrow J, Roberts L, Bishop P. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest 1994;93:493-8.
55. Bakheet T, Frevel M, Williams B, Greer W, Khabar K. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 2001;29:246-54.
56. Khabar K, Bakheet T, Williams B. AU-rich transient response transcripts in the human genome: expressed sequence tag clustering and gene discovery approach. Genomics 2005;85:165-75.
57. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005;33:W741-8.